Trial Profile
Reproducibility Study of OABSS and Its Response to Treatment in Indonesia - Part 2: Responsiveness.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Jan 2011
Price :
$35
*
At a glance
- Drugs Solifenacin (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- Acronyms RESORT-2
- Sponsors Astellas Pharma
- 12 Jan 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Jan 2011 Planned end date changed from 1 Dec 2010 to 1 Jan 2011 as reported by ClinicalTrials.gov.
- 10 Jan 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.